Lung cancer: open trials in Costa Rica

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Onco Tech, S.A. (Site 4102), San José

  Registry updated 2026-10-26

• NCT06868277

  A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  San José · San José Capital · Santa Ana

  Registry updated 2026-09-25

• NCT07524803

  Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

  Research · Latin American Consortium for the Lung Cancer Research

  Centro de Investigacion y Manejo del Cancer (CIMCA), San José

  Registry updated 2026-04-13

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error